Arkolith/Insider Trading/AIM/Form 4

Appelrouth Stewart

DirectorAIM ImmunoTech Inc. (AIM) · full profile →Form 4 · filed Mar 10, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
22
1 non-derivative · 21 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 10, 2023Other(J)68K$1.23$84K149K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 8, 2023Other(J)3K—$03K
Mar 8, 2023Other(J)1K—$01K
Mar 8, 2023Other(J)1K—$01K
Mar 8, 2023Other(J)2K—$02K
Mar 8, 2023Other(J)1K—$01K
Mar 8, 2023Other(J)2K—$02K
Mar 8, 2023Other(J)11—$011
Mar 8, 2023Other(J)2K—$02K
Mar 8, 2023Other(J)568—$0568
Mar 8, 2023Other(J)25K—$025K
Mar 8, 2023Other(J)25K—$025K
Mar 8, 2023Other(J)25K—$025K
Mar 8, 2023Other(J)338—$0338
Mar 8, 2023Other(J)295—$0295
Mar 8, 2023Other(J)287—$0287
Mar 8, 2023Other(J)250—$0250
Mar 8, 2023Other(J)196—$0196
Mar 8, 2023Other(J)196—$0196
Mar 8, 2023Other(J)163—$0163
Mar 8, 2023Other(J)143—$0143
Mar 8, 2023Other(J)150—$0150

Transaction Codes

J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-23-007238) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML